TGFB1 and neoplasm: This study validated that PLTs are likely to contribute to the progression of cancer by promoting neoangiogenesis, increasing microvessel permeability and the extravasation of cancer cells, generating growth factors (e.g., VEGF, PDGF, and TGF-β), and promoting the interaction between tumor cells and endothelia at metastatic sites [20].